HUNAN DAJIAWEIKANG PHARMACEUTICAL INDUSTRY CO.,LTD

Altre lingue Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd

Azioni

301126

CNE1000054V3

Prezzo di chiusura Shenzhen S.E. Altri mercati azionari 00:00:00 21/06/2024			Variaz. 5gg	Var. 1 gen.
8,93 ^CNY	+0,56%		-1,22%	-31,47%

05/06	Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SZSE:301126) inizia un riacquisto di azioni per un valore di CNY 15 milioni, in base all'autorizzazione approvata il 15 aprile 2024.	CI
22/04	Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd commences an Equity Buyback for CNY 15 million worth of its shares, under the authorization approved on April 15, 2024.	05/06
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024	22/05
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Approves Cash Dividend for 2023	15/05
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	22/04
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd announced that it expects to receive CNY 119.999994 million in funding	28/03
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	24/10/23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Approves Board Elections	11/10/23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd signed the share acquisition agreement to acquire 51% stake in Shanxi Simaile Pharmaceutical Chain Co., Ltd. from Yang Jinjiang, Liu Hongming for approximately CNY 330 million.	19/09/23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd agreed to acquire Yinchuan Meihetai Pharmaceutical Chain Co., Ltd. from Xie Huiyang and Xie Xiaolong for approximately CNY 250 million.	04/07/23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Implements Final Cash Dividend of A Shares for the Year 2022, Payable on June 12, 2023	02/06/23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Approves Final Cash Dividend for 2022	15/05/23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd cancelled the transaction announced on May 18, 2022	28/04/23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd announced that it expects to receive CNY 300 million in funding	28/04/23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Proposes Final Cash Dividend for the Year 2022	24/04/23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	21/04/23
Hunan Tongjian Pharmacy to Buy 86% Stake in Local Peer For 341 Million Yuan	03/01/23
Hunan Tongjian Pharma to Buy 86% of Local TCM Maker For 341 Million Yuan	23/12/22
Certain A Shares of Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd. are subject to a Lock-Up Agreement Ending on 8-DEC-2022.	08/12/22
Hunan Dajiaweikang Pharma to Buy 85.7% Stake in Pharma Firm	16/11/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd

Azioni

301126

CNE1000054V3

Altre lingue

Filtri